The Efficacy and Safety of Batroxobin Combined With Anticoagulation in Cerebral Venous Sinus Thrombosis
Cerebral Venous Sinus Thrombosis
Enrolment: 60 · Results not recorded
Loading the evidence…
Biologic
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Cerebral Venous Sinus Thrombosis
Enrolment: 60 · Results not recorded
Cerebral Venous Thrombosis
Enrolment: 72 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: nigrostriatal pathway injury, mechanical brain injury model
Batroxobin improved long-term motor function, reduced acute neuronal apoptosis and inflammation, and attenuated scar formation and lesion size at 4 and 14 days after nigrostriatal pathway injury in mice.
Extraction: extract · Supplied extraction confidence: 0.5. Machine-extracted fields require source verification.